Loading...

Aptinyx Inc.

APTX•NASDAQ
Healthcare
Biotechnology
$0.10
$0.003(3.17%)

Aptinyx Inc. (APTX) Stock Overview

Explore Aptinyx Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 61.4/100

Key Financials

Market Cap0
P/E Ratio-0.10
EPS (TTM)$-0.98
ROE-0.97%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.03

APTX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Aptinyx Inc. (APTX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.03.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.10 and a market capitalization of 0. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
3.17%
3-Month Change
49.30%
6-Month Change
32.96%
Year-to-Date (YTD) Change
N/A
1-Year Change
-77.14%
3-Year Change
-97.41%
5-Year Change
-98.19%
All-Time (Max) Change
-99.52%

Contact Information

https://www.aptinyx.com
847 871 0377
909 Davis Street, Evanston, IL, 60201

Company Facts

12 Employees
IPO DateJun 21, 2018
CountryUS

Frequently Asked Questions

;